Cargando...
Oral metronomic chemotherapy for recurrent & refractory epithelial ovarian cancer: A retrospective analysis
BACKGROUND & OBJECTIVES: Advanced epithelial ovarian cancer (EOC) is associated with dismal outcome and progression-free survival (PFS) shortens with each subsequent relapse. For patients with recurrent and platinum refractory disease, therapeutic options are limited. Oral metronomic therapy (OM...
Guardado en:
| Publicado en: | Indian J Med Res |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Wolters Kluwer - Medknow
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7038810/ https://ncbi.nlm.nih.gov/pubmed/32048620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijmr.IJMR_2030_18 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|